At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.
In this podcast, Dr. Sumanta Pal gives an overview of research that will be shared at the 2017 Genitourinary Cancers Symposium.
A new study in the Journal of Clinical Oncology finds a link between voluntary weight loss and lower risk of endometrial cancer, a type of uterine cancer.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Exercise, Emotional Health, and Long-Term Care: Highlights from the 2017 Cancer Survivorship Symposium: Advancing Care and Research
In this podcast, Cancer.Net Editor in Chief Lidia Schapira discusses new research from the 2017 Cancer Survivorship Symposium. She talks about physical activity, psychological care for partners of people with cancer, and long-term care in survivors of thyroid cancer.
At the 2017 Gastrointestinal Cancers Symposium, new research will be presented that may help improve the treatment of metastatic colorectal cancer, esophageal cancer, and rectal cancer.
In this podcast, Dr. Michael E. Williams reports on the highlights from the 2016 American Society of Hematology Annual Meeting.
In this podcast, Dr. Julie Gralow talks about some of the research highlights from the San Antonio Breast Cancer Symposium.
Sanford Jeames is a research advocate and a patient advocate. In this Voices on Cancer post, he describes the critical roles he plays to help researchers, clinicians, and communities understand the human impact of cancer.
Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month.